Skip to main content
. Author manuscript; available in PMC: 2016 Jan 6.
Published in final edited form as: Hum Pathol. 2015 May 30;46(9):1323–1330. doi: 10.1016/j.humpath.2015.05.014

Fig. 2.

Fig. 2

Overall and disease-specific survival by NF1 genetic alterations (loss) from the TCGA dataset. NF1 genetic loss shows no effect in overall (A) or disease-specific survival (B) in glioblastoma. However, in the lower-grade glioma group, NF1 loss was associated with significantly worse overall (C) and disease-specific survival (D) (log-rank test). (WT = wild type; NF1 loss includes homozygous deletions and predominantly mutations with functional consequences).